Researchers assessed the safety and immunogenicity of an egg culture-based quadrivalent inactivated nonadjuvanted subunit influenza vaccine.
Influenza vaccination is associated with a reduced Alzheimer disease risk among older U.S. adults, according to a study published online.
Throughout the 2021 to 2022 influenza season, the predominant virus was influenza A(H3N2), according to published research.
Using a large US claims database, researchers compared the risk for incident AD between patients with and without a prior influenza vaccination.
Simultaneous administration of COVID-19 mRNA booster and influenza vaccines may increase the likelihood of systemic reactions.
Researchers evaluated 3 different study designs to determine their accuracy in measuring influenza vaccine effectiveness among older patients.
The National Institutes of Health Clinical Center has begun a phase I trial of a potential universal influenza vaccine.
Researchers assessed the association between the onset of systemic vasculitis following mRNA COVID-19 vaccination.
Does influenza vaccination protect patients hospitalized for diabetes against the risk for poor outcomes and complications?
Researchers assessed the protective effects of influenza vaccination among older adults with cardiovascular disease.
Physical activity and acute exercise offer some benefit for influenza vaccination response, according to a review published online.
A phase 2 study assessed safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine with a mRNA-1273 vaccine booster dose in older adults.
The test is the first non-prescription multi-analyte COVID-19 test that allows individuals to test nasal swab samples self-collected at home.
Researchers evaluated the risk of confounding bias in simulated test-negative studies that assessed estimated COVID-19 and influenza vaccine effectiveness.
In patients with severe pneumonia, how do clinical characteristics, comorbidities, and mortality rates differ between those with vs without COVID-19?
Researchers conducted a study that compared early treatment with inhaled zanamivir vs oral oseltamivir on the risk for hospitalization or death due to influenza infection.
For children aged 5 to 17 years with asthma, quadrivalent live attenuated influenza vaccine (LAIV4) is noninferior to quadrivalent inactivated influenza vaccine (IIV4) for frequency of asthma exacerbations.
There is a small absolute risk for shoulder conditions after intramuscular vaccination administered in the deltoid muscle.
Researchers compared the incidence of intra-familial influenza transmission after treatment of the first family member with baloxavir marboxil vs oseltamivir.
Researchers examined the safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine and a third dose of mRNA-1273 vaccine booster concomitantly.